LLY - ELI LILLY & Co


1007.73
-10.240   -1.016%

Share volume: 2,836,879
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$1,017.97
-10.24
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 04-30-2024 08-08-2024 10-30-2024 02-19-2025 05-01-2025 08-07-2025 10-30-2025 02-12-2026
Total revenue 8.768 B 11.303 B 11.439 B 13.533 B 12.729 B 15.558 B 17.601 B 19.292 B
Cost of revenue 1.674 B 2.170 B 2.171 B 2.404 B 2.224 B 2.448 B 3.008 B 3.372 B
Gross profit 7.095 B 9.133 B 9.268 B 11.129 B 10.504 B 13.110 B 14.593 B 15.920 B
    28.73% 1.49% 20.08% -5.61% 24.81% 11.31% 9.10%  
Operating expenses 4.586 B 4.983 B 7.660 B 5.636 B 6.774 B 6.243 B 6.862 B 7.462 B
Selling general and admin 1.952 B 2.117 B 2.100 B 2.425 B 2.469 B 2.753 B 2.741 B 3.132 B
Research and development 2.633 B 2.866 B 5.561 B 3.212 B 4.305 B 3.490 B 4.121 B 4.330 B
Total expenses 4.586 B 5.418 B 7.742 B 5.980 B 6.809 B 6.243 B 7.227 B 7.546 B
    18.15% 42.90% -22.76% 13.86% -8.32% 15.76% 4.41%  
Operating income 2.509 B 3.715 B 1.526 B 5.149 B 3.695 B 6.867 B 7.366 B 8.374 B
Ebit 2.536 B 3.517 B 1.588 B 5.039 B 3.456 B 6.776 B 7.232 B 8.266 B
Pretax income 2.536 B 3.517 B 1.588 B 5.039 B 3.456 B 6.776 B 7.232 B 8.266 B
    38.69% -54.84% 217.22% -31.41% 96.07% 6.73% 14.29%  
Income tax 293.200 M 550.200 M 618.100 M 628.900 M 696.800 M 1.116 B 1.650 B 1.628 B
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 2.243 B 2.967 B 970.300 M 4.410 B 2.759 B 5.661 B 5.583 B 6.638 B
    32.28% -67.30% 354.48% -37.43% 105.14% -1.38% 18.90%